Skip to content
PubMed This is a summary of 74 peer-reviewed journal articles Updated
Neurology

Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease (PCWH): A Patient Guide

At a Glance

PCWH is a rare condition caused by a SOX10 mutation that can affect the brain, peripheral nerves, hearing, pigmentation, and bowel function. Symptoms vary widely, so children benefit from coordinated specialist care, individualized monitoring, and therapy.

This guide is written for parents and caregivers of children diagnosed with Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease (PCWH).

PCWH is a rare, complex genetic condition that affects multiple systems in the body simultaneously. It is considered a particularly broad form of Waardenburg-Shah syndrome, which typically combines changes in hearing and pigmentation with bowel challenges [1][2]. What distinguishes PCWH is the addition of neurological components that affect both the brain and the nerves that travel throughout the rest of the body [3]. Because it impacts so many different areas, every child’s experience with the condition is unique, with symptoms that can range from very mild to more profound.

The biological root of this condition is a mutation in a single gene called SOX10. This gene acts as a master regulator during a baby’s development in the womb, providing essential instructions to a group of cells that migrate throughout the body [4]. These cells eventually become the nerves that control digestion, the cells that produce pigment in the skin and eyes, and the structures of the inner ear. SOX10 is also crucial for the development of the “insulation” known as myelin, which wraps around nerves in both the brain and the limbs to help signals travel quickly and clearly [5][6]. When this gene is not working correctly, it can lead to the diverse symptoms of PCWH, including muscle weakness, developmental delays, hearing loss, and intestinal issues.

Living with PCWH requires a highly coordinated approach to care. Because the condition involves the brain, the gut, and the ears, a multidisciplinary team of specialists—including neurologists, surgeons, and audiologists—is essential for supporting a child’s health and development [7]. While the medical name for this condition is long and can be intimidating, it serves as a roadmap for doctors to monitor each system effectively. By focusing on each child’s specific needs through individualized surveillance and specialized therapy, families and medical teams work together to help children reach their full potential [8].

Common questions in this guide

What is PCWH, and which parts of the body can it affect?
PCWH is a rare genetic condition caused by a mutation in the SOX10 gene. It can affect the brain and peripheral nerves, the inner ear, pigment-producing cells, and the bowel, so children may have different combinations and severity of symptoms.
How does a SOX10 mutation lead to PCWH symptoms?
SOX10 helps guide the development of nerves, inner-ear structures, pigment-producing cells, and myelin, the insulating layer around many nerves. When the gene does not work correctly, nerve signals and the development of hearing, pigmentation, movement, and bowel function can be affected.
What signs and symptoms can children with PCWH have?
Possible features include muscle weakness, developmental delays, hearing loss, pigmentation changes such as white hair patches, and bowel or intestinal problems. Inner-ear differences may also affect balance, and symptoms can range from mild to profound.
Which specialists may be involved in PCWH care?
A child’s care may include a neurologist, surgeon, audiologist, and genetic counselor working as a multidisciplinary team. The exact team depends on the child’s symptoms and may change as the child grows.
How is a child with PCWH monitored and supported?
Monitoring should be individualized and may include bowel function, nutrition, development, hearing, and neurological health. Specialized therapy and coordination among specialists can help address the child’s changing needs.
Is PCWH the same as Waardenburg-Shah syndrome?
PCWH is considered a particularly broad form of Waardenburg-Shah syndrome. It shares hearing, pigmentation, and bowel features with that syndrome but also includes more extensive involvement of the brain and peripheral nerves.
What can a genetic counselor explain about PCWH?
A genetic counselor can review the child’s specific SOX10 mutation, discuss whether it is commonly associated with PCWH, and explain inheritance and recurrence risks. They can also help families decide which relatives’ symptoms or genetic information may be useful to share with the care team.

Get notified when new evidence is published on Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    A de novo deletion mutation in SOX10 in a Chinese family with Waardenburg syndrome type 4.

    Wang X, Zhu Y, Shen N, et al.

    Scientific reports 2017; (7()):41513 doi:10.1038/srep41513.

    PMID: 28128317
  2. 2

    Novel SOX10 Mutations in Waardenburg Syndrome: Functional Characterization and Genotype-Phenotype Analysis.

    Thongpradit S, Jinawath N, Javed A, et al.

    Frontiers in genetics 2020; (11()):589784 doi:10.3389/fgene.2020.589784.

    PMID: 33362852
  3. 3

    Neurological Waardenburg-Shah syndrome: a diagnostic challenge in a child with skin hypopigmentation and neurological manifestation.

    Ng BW, Lee JS, Toh TH, Ngu LH

    BMJ case reports 2022; (15(6)) doi:10.1136/bcr-2022-250360.

    PMID: 35725288
  4. 4

    SOX10: 20 years of phenotypic plurality and current understanding of its developmental function.

    Pingault V, Zerad L, Bertani-Torres W, Bondurand N

    Journal of medical genetics 2022; (59(2)):105-114 doi:10.1136/jmedgenet-2021-108105.

    PMID: 34667088
  5. 5

    Additive dominant effect of a SOX10 mutation underlies a complex phenotype of PCWH.

    Ito Y, Inoue N, Inoue YU, et al.

    Neurobiology of disease 2015; (80()):1-14.

    PMID: 25959061
  6. 6

    Myrf guides target gene selection of transcription factor Sox10 during oligodendroglial development.

    Aprato J, Sock E, Weider M, et al.

    Nucleic acids research 2020; (48(3)):1254-1270 doi:10.1093/nar/gkz1158.

    PMID: 31828317
  7. 7

    Radiologic Phenotyping in Patients with SOX10 Pathogenic Variants: Insights into Neck, Brain, and Temporal Bone Abnormalities.

    Gentile F, Clement E, Rajput K, et al.

    AJNR. American journal of neuroradiology 2026; (47(10)):2609-2614 doi:10.3174/ajnr.A9322.

    PMID: 41887743
  8. 8

    Genetic Variability of SOX10-Related Disorders within an Italian Family: Straddling the Line between Kallmann and Waardenburg Syndrome.

    Graziani L, Carriero ML, Pozzi F, et al.

    Molecular syndromology 2024; (15(4)):339-346 doi:10.1159/000536574.

    PMID: 39119450

This PCWH guide is for informational purposes only and does not constitute medical advice. Your child’s neurologist, genetic counselor, audiologist, surgeon, and other clinicians should interpret the SOX10 findings and create an individualized care plan.